Current KL2 Scholars
Carmen M. Dickinson-Copeland, PhD, MSCR
Morehouse School of Medicine
- Instructor, Department of Microbiology, Biochemistry and Immunology
Lead Mentor: Priscilla E. Igho-Pemu, MBBS, MSCR, FACP
Dr. Dickinson-Copeland is an Instructor in the Department of Microbiology, Biochemistry and Immunology at Morehouse School of Medicine. Her KL2 research is entitled "Progenitor cell response to lead exposure in children from rural versus urban counties in Georgia,” which focuses on the identification of molecular biomarkers, socioeconomic and environmental risk factors associated with lead exposure and toxicity among children living in both rural and urban settings. Dr. Dickinson-Copeland's research combines her biomedical translational experience with her training in health policy leadership. Her doctoral thesis included the identification and assessment of the functional roles of biomarkers for microvascular dysfunction in pediatric cerebral malaria. As a fellow of the Satcher Health Policy Leadership Institute, she received training in leadership development, health policy, and health equity. Dr. Dickinson-Copeland’s long-term goal is to advance health equity through the collaborative development of evidence-based health policy.
Ronald C. Eldridge, PhD, MPH
- Research Assistant Professor, Nell Hodgson Woodruff School of Nursing
Lead Mentor: Deborah Watkins Bruner, RN, PhD, FAAN
Dr. Eldridge is a Research Assistant Professor at the Nell Hodgson Woodruff School of Nursing. His background and expertise in epidemiology, public health, and methods has driven his research in the biological mechanisms related to cancer prevention and clinical translation. In his KL2 project titled “Progressing towards precision medicine in human papillomavirus and non-human papillomavirus head and neck cancer through high-resolution metabolomics”, Dr. Eldridge is using the cutting edge in omics research to metabolically characterize HPV-associated and non-HPV-associated head and neck cancer patients. He will then pair that metabolomics data with machine learning algorithms to predict head and neck cancer patient survival.
Andre L. Holder, MD, MS
- Assistant Professor of Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, School of Medicine
Lead Mentor: Timothy G. Buchman, PhD, MD
Dr. Holder is an Assistant Professor of Medicine at the Emory University School of Medicine. The title of his KL2 project is "Characterizing Patients at Risk for Sepsis Through Big Data." He will test whether complex measurements with proven physiologic significance (e.g. pulse pressure variation, heart rate variability metrics), and novel ways of looking at existing physiologic waveforms (blood pressure, heart rate, etc.) are linked to subtle pathophysiology to sepsis, prior to its onset. Machine learning algorithms created by this project will use features deemed "important" in an existing real-time sepsis forecasting algorithm to create phenotypes based on disease trajectory, and determine how clinical actions impact those trajectories. Other areas of research interest include early sepsis resuscitation, cardiopulmonary resuscitation, and hemodynamic monitoring.
Joshua M Levy, MD, MPH
- Assistant Professor, Department of Otolaryngology-Head & Neck Surgery
Lead Mentor: David Guidot, MD
Dr. Levy is Assistant Professor of Otolaryngology and Director of Resident Research in the Department of Otolaryngology—Head and Neck Surgery at Emory University. He completed his public health and medical training at Tulane University in New Orleans, LA, where he also completed his residency in Otolaryngology. Upon completing residency in 2015, he joined Dr. Tim Smith for fellowship in Rhinology, Sinus, and Skull Base Surgery at Oregon Health & Science University in Portland, OR. Academically, Dr. Levy is interested in aspirin exacerbated respiratory disease, and leads a multi-disciplinary research team and dedicated clinic devoted to improving outcomes for patients with combined allergy, sinus, and airway conditions. He is currently supported by the National Center for Advancing Translational Sciences (KL2) as well as foundation awards from the Triological Society and American Academy of Otolaryngic Allergy.
Caitlin A. Moran, MD, MSc
- Assistant Professor of Medicine, Division of Infectious Diseases
Lead Mentor: Igho Ofotokun, MD, MSc
Dr. Moran is an Assistant Professor of Medicine at Emory University School of Medicine. Her clinical experiences as an infectious diseases physician have driven her research interests in non-AIDS comorbidities in women living with HIV. Her KL2 project entitled “Exploring the role of sex hormones in subclinical cardiovascular disease in women with and without HIV” aims to study the association between estrogen receptor gene expression, systemic inflammation, and subclinical cardiovascular disease progression in women living with and at risk for HIV in the Women’s Interagency HIV Study (WIHS) cohort.
Andrea Sikora Newsome, PharmD, BCPS, BCCCP
University of Georgia
- Clinical Assistant Professor, The University of Georgia College of Pharmacy
- Critical Care Clinical Pharmacist, Augusta University Medical Center
Lead Mentor: Somanath P.R. Shenoy, MSc, PhD, FAHA
Dr. Andrea Sikora Newsome is a Clinical Assistant Professor at The University of Georgia College of Pharmacy. She completed her Doctor of Pharmacy training at The University of Georgia College of Pharmacy followed by two years of post-graduate residency training at The University of North Carolina Medical Center specializing in critical care. Her practice site is Augusta University Medical Center in Augusta, GA. Her area of research interest is the vascular and hemodynamic changes that occur in critical illness. Her KL2 project is entitled "Stromelysin-1 (MMP3) as a diagnostic and prognostic biomarker for acute respiratory distress syndrome."
Megha K. Shah, MD, MSc
- Assistant Professor, Department of Family and Preventive Medicine, School of Medicine
Lead Mentor: K.M. Venkat Narayan, MD, MSc, MBA
Dr. Shah is an Assistant Professor of Family and Preventive Medicine at Emory University. Prior to her position at Emory, she was a Robert Wood Johnson Clinical Scholar at University of Michigan. Her research interests are focused on community-partnered approaches to chronic disease management, specifically for diabetes. A particular focus is on community-partnered translational research for diabetes prevention and self-management. Dr. Shah’s KL2 project is entitled “Better Together: Leveraging primary care and social network resources to create a patient-centered approach to improve diabetes among South Asians”.
Vinita Singh, MD
- Assistant Professor, Department of Anesthesiology, School of Medicine
Lead Mentor: Theresa Gillespie, PhD, MA, BSN
Dr. Singh is an Assistant Professor of Anesthesiology in the Emory University School of Medicine. The title of her KL2 research project is “Efficacy, safety, and feasibility of intranasal ketamine for uncontrolled cancer pain." Intranasal (NAS) ketamine represents an exciting approach to reduce uncontrolled cancer related pain and potential method of delivering ketamine in a needle-free, patient-friendly way as an outpatient maintenance therapy. Her research project is to conduct a clinical of intranasal ketamine in patients with cancer related pain and determine its effects in terms of patient reported outcomes as well as outcomes measured by the investigators. This project will also determine pharmacokinetics of intranasal ketamine. Her long-term goal is to become a national/international expert in non-opioid based therapies for pain.
Aaron Trammell, MD, MSc
- Assistant Professor of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, School of Medicine
Lead Mentor: C. Michael Hart, MD
Dr. Trammell is Assistant Professor of Medicine at Emory University School of Medicine. He has clinical and research focus in pulmonary hypertension, a state of abnormally elevated blood pressure in the lungs. Dr. Trammell’s KL2 project, “Metabolic dysfunction and pulmonary hypertension”, will explore the impact of metabolic disease in complementary epidemiologic and translational studies. Prior work from others supports a role of insulin resistance in pulmonary arterial hypertension, a rare subset of pulmonary hypertension. In his KL2 work, he will use a longitudinal cohort he developed from VA data to estimate the impact of diabetes and its treatments on outcome in veterans with more common forms of pulmonary hypertension. Additionally, he will work with laboratory collaborators to describe differences in mitochondrial metabolism between subjects with and without pulmonary hypertension.